RAONF
Price:
$2.6
Market Cap:
$473.25M
Based in Sydney, Australia, Race Oncology Limited is an Australian precision oncology firm that commenced operations in 2011. The company's primary focus is the development of Zantrene, a potent small molecule designed to inhibit the fatso/fat mass and obesity associated protein (FTO). This therapeutic agent is currently in Phase II/III clinical trials, exploring its potential to treat a range of cancers, including melanoma, clear cell renal cell carcinoma, acute myeloid leukaemia, breast cancer, and ovarian cancer. Race Oncology actively pursues preclinical research through a program with the University of Newcastle to investigate Zantrene further, and maintains a strategic partnership with...[Read more]
Industry
Biotechnology
IPO Date
2021-03-09
Stock Exchange
OTC
Ticker
RAONF
According to Race Oncology Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 452.31M. This represents a change of 54.15% compared to the average of 293.42M of the last 4 quarters.
The mean historical Enterprise Value of Race Oncology Limited over the last ten years is 153.83M. The current 452.31M Enterprise Value has changed 29.30% with respect to the historical average. Over the past ten years (40 quarters), RAONF's Enterprise Value was at its highest in in the December 2021 quarter at 492.13M. The Enterprise Value was at its lowest in in the June 2016 quarter at -1302691.00.
Average
153.83M
Median
131.21M
Minimum
3.48M
Maximum
471.32M
Discovering the peaks and valleys of Race Oncology Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.49%
Maximum Annual Enterprise Value = 471.32M
Minimum Annual Increase = -66.66%
Minimum Annual Enterprise Value = 3.48M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 189.53M | -32.84% |
| 2024 | 282.20M | 44.15% |
| 2023 | 195.77M | -33.17% |
| 2022 | 292.91M | -37.85% |
| 2021 | 471.32M | 546.65% |
| 2020 | 72.89M | 1.99% |
| 2019 | 3.48M | -66.66% |
| 2018 | 10.44M | 2.72% |
| 2017 | 10.17M | 5.72% |
| 2016 | 9.62M | 3.49% |
The current Enterprise Value of Race Oncology Limited (RAONF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
222.50M
5-year avg
286.35M
10-year avg
153.83M
Race Oncology Limited’s Enterprise Value is less than BioInvent International AB (publ) (1.16B), less than MedinCell S.A. (1.04B), greater than Avacta Group Plc (330.19M), greater than PureTech Health plc (189.27M), less than Healios K.K. (21.33B), greater than GenSight Biologics S.A. (23.81M), greater than Northwest Biotherapeutics, Inc. (374.44M), less than Clinuvel Pharmaceuticals Limited (455.71M), less than Verano Holdings Corp. (846.53M), less than Nxera Pharma Co., Ltd. (134.86B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.16B | $216.40M | |
| 1.04B | $1.23B | |
| 330.19M | $454.97M | |
| 189.27M | $413.81M | |
| 21.33B | $193.79M | |
| 23.81M | $30.99M | |
| 374.44M | $312.23M | |
| 455.71M | $348.84M | |
| 846.53M | $470.36M | |
| 134.86B | $567.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Race Oncology Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Race Oncology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Race Oncology Limited's Enterprise Value?
What is the highest Enterprise Value for Race Oncology Limited (RAONF)?
What is the 3-year average Enterprise Value for Race Oncology Limited (RAONF)?
What is the 5-year average Enterprise Value for Race Oncology Limited (RAONF)?
How does the current Enterprise Value for Race Oncology Limited (RAONF) compare to its historical average?